Biological evaluation and molecular docking studies of AA3052, a compound containing a μ-selective opioid peptide agonist DALDA and d-Phe-Phe-d-Phe-Leu-Leu …
A Kowalczyk, P Kleczkowska, M Rękawek… - European Journal of …, 2016 - Elsevier
The design of novel drugs for pain relief with improved analgesic properties and diminished
side effect induction profile still remains a challenging pursuit. Tolerance is one of the most …
side effect induction profile still remains a challenging pursuit. Tolerance is one of the most …
[PDF][PDF] ÔØ Å ÒÙ× Ö ÔØ
MBZ BALLET - 2016 - academia.edu
The design of novel drugs for pain relief with improved analgesic properties and diminished
side effect induction profile still remains a challenging pursuit. Tolerance is one of the most …
side effect induction profile still remains a challenging pursuit. Tolerance is one of the most …
Biological evaluation and molecular docking studies of AA3052, a compound containing a μ-selective opioid peptide agonist DALDA and d-Phe-Phe-d-Phe-Leu-Leu …
A Kowalczyk, P Kleczkowska, M Rękawek… - European Journal of …, 2016 - infona.pl
The design of novel drugs for pain relief with improved analgesic properties and diminished
side effect induction profile still remains a challenging pursuit. Tolerance is one of the most …
side effect induction profile still remains a challenging pursuit. Tolerance is one of the most …
[PDF][PDF] Biological evaluation and molecular docking studies of AA3052, a compound containing a μ-selective opioid peptide agonist DALDA and d-Phe-Phe-d-Phe-Leu …
A Kowalczyk, P Kleczkowska… - EUROPEAN …, 2016 - publicatio.bibl.u-szeged.hu
The design of novel drugs for pain relief with improved analgesic properties and diminished
side effect induction profile still remains a challenging pursuit. Tolerance is one of the most …
side effect induction profile still remains a challenging pursuit. Tolerance is one of the most …
[引用][C] Biological evaluation and molecular docking studies of AA3052, a compound containing a mu-selective opioid peptide agonist DALDA and D-Phe-Phe-D-Phe …
A Kowalczyk, P Kleczkowska… - European Journal …, 2016 - researchportal.vub.be
Biological evaluation and molecular docking studies of AA3052, a compound containing a
mu-selective opioid peptide agonist DALDA and D-Phe-Phe-D-Phe-Leu-Leu-NH2, a substance …
mu-selective opioid peptide agonist DALDA and D-Phe-Phe-D-Phe-Leu-Leu-NH2, a substance …
[PDF][PDF] Biological evaluation and molecular docking studies of AA3052, a compound containing a μ-selective opioid peptide agonist DALDA and D-Phe-Phe-D-Phe …
P Kleczkowska - 2016 - core.ac.uk
The design of novel drugs for pain relief with improved analgesic properties and diminished
side effect induction profile still remains a challenging pursuit. Tolerance is one of the most …
side effect induction profile still remains a challenging pursuit. Tolerance is one of the most …
Biological evaluation and molecular docking studies of AA3052, a compound containing a μ-selective opioid peptide agonist DALDA and d-Phe-Phe-d-Phe-Leu-Leu …
A Kowalczyk, P Kleczkowska… - … : official journal of …, 2016 - pubmed.ncbi.nlm.nih.gov
The design of novel drugs for pain relief with improved analgesic properties and diminished
side effect induction profile still remains a challenging pursuit. Tolerance is one of the most …
side effect induction profile still remains a challenging pursuit. Tolerance is one of the most …
[引用][C] Biological evaluation and molecular docking studies of AA3052, a compound containing a μ-selective opioid peptide agonist DALDA and D-Phe-Phe-D-Phe …
A Kowalczyk, P Kleczkowska, M Rękawek… - European Journal of …, 2016 - elibrary.ru
Biological evaluation and molecular docking studies of AA3052, a compound containing a μ-
selective opioid peptide agonist DALDA and D-Phe-Phe-D-Phe-Leu-Leu-NH< sub> …
selective opioid peptide agonist DALDA and D-Phe-Phe-D-Phe-Leu-Leu-NH< sub> …
Biological evaluation and molecular docking studies of AA3052, a compound containing a μ-selective opioid peptide agonist DALDA and D-Phe-Phe-D-Phe-Leu-Leu …
A Kowalczyk, P Kleczkowska, M Rękawek… - EUROPEAN …, 2016 - real.mtak.hu
The design of novel drugs for pain reliefwith improved analgesic properties and diminished
side effect induction profile still remains a challenging pursuit. Tolerance is one of themost …
side effect induction profile still remains a challenging pursuit. Tolerance is one of themost …
Biological evaluation and molecular docking studies of AA3052, a compound containing a μ-selective opioid peptide agonist DALDA and d-Phe-Phe-d-Phe-Leu-Leu …
A Kowalczyk, P Kleczkowska, M Rękawek… - European Journal of …, 2016 - europepmc.org
The design of novel drugs for pain relief with improved analgesic properties and diminished
side effect induction profile still remains a challenging pursuit. Tolerance is one of the most …
side effect induction profile still remains a challenging pursuit. Tolerance is one of the most …